Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder
Article in Journal of Neuroimmunology (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
An update on the biologics for the treatment of antiphospholipid syndrome
Article in Frontiers in Immunology (May 2023)
Efficacy of telitacicept in patients with lupus‐ and antiphospholipid syndrome‐associated refractory thrombocytopenia
Article in Rheumatology & Autoimmunity (May 2023)